期刊文献+

辛伐他汀与贝那普利单用或联用治疗糖尿病肾病240例 被引量:2

下载PDF
导出
摘要 目的:探讨辛伐他汀与贝那普利治疗糖尿病肾病单独用药及联合用药的疗效。方法:选择医院2010年1月至2013年12月收治的糖尿病肾病患者240例作为研究对象,随机分为3组,即辛伐他汀组、贝那普利组及联合用药组,每组80例。辛伐他汀组给予辛伐他汀治疗,贝那普利组给予贝那普利治疗,联合用药组给予辛伐他汀和贝那普利联合治疗,观察治疗各组患者肾功能的变化情况和疗效。结果:联合用药组的有效率高于辛伐他汀组与贝那普利组,联合用药组的尿素氮、血肌酐低于辛伐他汀组与贝那普利组,差异均有统计学意义(P<0.05)。结论:辛伐他汀与贝那普利联合用药治疗糖尿病肾病疗效优于单独用药,值得临床借鉴应用。
出处 《长江大学学报(自科版)(下旬)》 CAS 2014年第6期31-32,共2页 Journal of Yangtze University
  • 相关文献

参考文献6

二级参考文献42

  • 1王先梅,杨丽霞,宋武战,齐峰,郭传明,石燕昆,赵颖,魏玲,王燕.盐酸贝那普利对自发性高血压大鼠肾脏纤维化的影响[J].第四军医大学学报,2006,27(20):1859-1862. 被引量:7
  • 2亓鲁光,刘贵阳,朱丹平,王娟,刘青.脉通方治疗Ⅳ期糖尿病肾病临床研究[J].中华中医药学刊,2007,25(8):1548-1550. 被引量:5
  • 3Domhorst A, Liiddeke HJ, Sreenan S, et al. Safety and efficacy of in- sulin detemir in clinical practice:14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort [J]. Int J Clin Praet,2008,61 (3) :523 -528.
  • 4Garber A, Henry R, Ratner R, et al. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEADY3 Mono) :a randomised, 52week, phase Ⅲ, double-blind, parallel-treatment trial [ J ]. Lancet, 2009,373 (9662) :473 - 481.
  • 5Vejakama P,Thakkinstian A, Lertrattananon D, et al. Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic pa- tients:a systematic review and network meta-analysis [ J ]. Diabetolo- gia,2012,55 ( 3 ) :566 - 578.
  • 6Lemley KV. When to initiate ACEI/ARB therapy in patients with type 1 and 2 diabetes [ J ]. Pediatr Nephrol, 2010,25 ( 10 ) :2021 - 2034.
  • 7Banes-Berceli AK, Shaw S, Ma G, et al. Effect of simvastatin on high glucose-and angiotensin Ⅱ-induced activation of the JAK/STAT path- way in mesangial cells [ J ]. Am J Physiol Renal Physiol, 2006, 291(1) :116 -121.
  • 8Kim SI, Han DC, Lee HB. Lovastatin inhibits transforming growth factor-betal expression in diabetic rat glomeruli and cultured rat me- sangial cells [ J ]. J Am Soc Nephro1,2000,11 ( 1 ) :80 - 87.
  • 9Pistrosch F, Passaner J, Herbrig K, et al. Effect of thiazolidinedione treatment on proteinuria and renal hemodynamic in type 2 diabetic patients with overt nephropathy [ J]. Horm Metab Res, 2012, 44(12) :914 -918.
  • 10Miyazaki Y, Cersosimo E, Triplitt C, et al. Rosiglitazone decreases al- buminuria in type 2 diabetic patients [ J ]. Kidney Int, 2007, 72( 11 ) :1367 - 1373.

共引文献6752

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部